1. Anti-inflammatory constituents from Perovskia atriplicifolia.
- Author
-
Ahmad, Ijaz, Fozia, Waheed, Abdul, Tahir, Nafisa Batool, and Rais, Aisha Kalsoom
- Subjects
- *
ANTI-inflammatory agents , *LAMIACEAE , *TRADITIONAL medicine , *LEUKOTRIENES , *PHYTOCHEMICALS , *THERAPEUTICS - Abstract
Context:Perovskia atriplicifoliaBenth (Labiantae) has long been used as a traditional herbal medicine for anti-inflammation in Pakistan; this prompted us to isolate anti-inflammatory compounds from this plant. Objective: The objective of this study was to isolate and characterize the anti-inflammatory principles fromPerovskia atriplicifolia. Materials and methods: The CHCl3-soluble fraction of the methanol extract of the whole plant on column chromatography yielded compounds1–6. The anti-inflammatory potential of the compounds1–6was evaluated by Leukotriene C4 (LTC4) Release Assay which was performed according to the established protocol. LTC4in the supernatant of each well was measured using an ELISA kit (Cayman Chemical Co., Ann Arbor, MI). Results: The bioassay-guided phytochemical investigation of the CHCl3soluble fraction of the methanol extract ofPerovskia atriplicifoliafurnished six compounds, abrotanone (1), abrotandiol (2), (+)-pinoresinol (3), (+)-syringaresinol (4), (+)-lariciresinol (5), and (+)-taxiresinol (6). The compounds (1–6) were evaluated for their inhibitory activities on LTC4release. Among the tested compounds, (+)-taxiresinol (6) exhibited the most potent inhibition of LTC4release with an IC50value of 3.4 ± 0.09 µM followed by compounds4,5,3,and2with an IC50value ranging from 7.9 ± 0.04 to 17.2 ± 0.07 µM. Abrotanone (1) showed the lowest inhibition of LTC4release with an IC50value of 35.1 ± 0.05 µM (the positive control, zileuton, 0.77 ± 0.05 µM). Conclusion: Compounds1–6were found to possess inhibitory activity and seem to have potential therapeutic effect on inflammatory diseases. [ABSTRACT FROM PUBLISHER]
- Published
- 2015
- Full Text
- View/download PDF